The American Diabetes Association recommends regular monitoring for patients using these medications
Depending on the type of cheese, different metabolites may be produced in the finished product as a result of the metabolic processes that take place in the cheese

Researchers theorize this may be because: GIP activation may counterbalance some GLP-1 effects on the gut Dose escalation schedule allows more gradual adaptation Different pharmacokinetic profile may produce less pronounced peaks Serious Side Effects (Both Medications): These are rare but require immediate medical attention: Pancreatitis: Severe abdominal pain that may radiate to the back Risk: Less than 1% with both medications Usually occurs in first few months of treatment Requires immediate discontinuation if suspected Gallbladder Problems: Gallstones, cholecystitis (gallbladder inflammation) Symptoms: Right upper abdominal pain, nausea, fever More common with rapid weight loss May require surgical intervention Kidney Problems: Dehydration from vomiting/diarrhea can affect kidney function Watch for decreased urination, swelling in legs Stay well-hydrated, especially during side effect periods Thyroid Tumors (Black Box Warning): Both medications carry warnings about thyroid C-cell tumors Based on rodent studies

Conventional treatments address either the bone or the surrounding soft tissue, rarely both simultaneously
Additionally, a few studies on obese patients found that carnitine supplementation improved blood glucose regulation and lipid metabolism, which may indirectly influence fat distribution over time
J Bone Miner Res PubMed Jalloh MA, Gregory PJ, Hein D, et al